aTyr Pharma, Inc. (ATYR) Profit Margins
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ATYRaTyr Pharma, Inc.Follow ATYR — free
—
Price chart with a free account
- Market cap
- 16.2M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2019 Dec 19 | FY2020 Dec 20 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Operating margin | -5445.0% | -152.2% | -446.8% | -15557.8% | -28899.6% | -40856.3% | — | |
| Net margin | -3844.5% | -155.2% | -436.5% | -14274.5% | -27243.8% | -39009.5% | — | |
| FCF margin | -4761.1% | -148.3% | -419.1% | -10605.1% | -29440.0% | -32664.7% | — |
USD millions · SEC XBRL
Every figure on this page comes from aTyr Pharma, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.